Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Usana Health Sciences (USNA) Equity Ratio (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Equity Ratio for 16 consecutive years, with 0.72 as the latest value for Q1 2026.

  • Quarterly Equity Ratio rose 0.9% to 0.72 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.72 through Jan 2026, up 0.9% year-over-year, with the annual reading at 0.72 for FY2026, 0.9% up from the prior year.
  • Equity Ratio for Q1 2026 was 0.72 at Usana Health Sciences, down from 0.73 in the prior quarter.
  • The five-year high for Equity Ratio was 0.81 in Q2 2024, with the low at 0.68 in Q2 2022.
  • Average Equity Ratio over 5 years is 0.74, with a median of 0.73 recorded in 2022.
  • The sharpest move saw Equity Ratio increased 10.48% in 2023, then fell 10.87% in 2025.
  • Over 5 years, Equity Ratio stood at 0.73 in 2022, then increased by 7.89% to 0.79 in 2023, then fell by 9.49% to 0.71 in 2024, then increased by 2.19% to 0.73 in 2025, then fell by 1.27% to 0.72 in 2026.
  • According to Business Quant data, Equity Ratio over the past three periods came in at 0.72, 0.73, and 0.72 for Q1 2026, Q3 2025, and Q2 2025 respectively.